Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nalan Ogan

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Clinical Respiratory Journal|December 29, 2019
Correlatıon of neutrophyle/lymphocyte ratio and pulmonary parameters with optic coherence tomography findings in stable chronic obstructive pulmonary diseasePinar Altiaylik Ozer, Nalan Ogan
Tuberkuloz Ve Toraks|November 12, 2019
Incidental pulmonary nodule frequency in TurkeyNalan Ogan, Ayşe Baha, Ebru Özan Sanhal, et al.
Turkish Thoracic Journal|October 8, 2020
The Effect of Serum Electrolyte Disturbances and Uric Acid Level on the Mortality of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseNalan Ogan, Ersin Günay, Ayşe Baha, et al.
Turkish Thoracic Journal|March 13, 2020
Does Nutritional Risk Screening 2002 Correlate with the Dyspnea Status of Patients with GOLD Stage C-D Chronic Obstructive Pulmonary Disease?Nalan Ogan, Fatma Yıldırım, Banu Süzen, et al.
Tuberkuloz Ve Toraks|January 5, 2026
The effect of intravenous low-dose thrombolytics on in-hospital mortality in patients with intermediate-high-risk pulmonary embolismAycan Yüksel, Ceren Ilgar Akelma, Nalan Ogan, et al.
Frontiers in Immunology|January 28, 2026
Serum paraoxonase-1 as a marker of oxidative stress and pulmonary dysfunction in sarcoidosis: association with disease activity and prognostic potentialMine Büşra Bozkürk, Ersin Günay, Nalan Ogan, et al.
European Journal of Clinical Pharmacology|February 24, 2024
Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?Onur Turan, Nalan Ogan, Fulsen Bozkus, et al.
Prostaglandins & Other Lipid Mediators|November 8, 2022
The association between total cholesterol and cognitive impairment in chronic obstructive pulmonary disease patientsHayriye Mihrimah Ozturk, Nalan Ogan, Mehmet Erdogan, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|August 15, 2019
Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia?Evrim Eylem Akpınar, Derya Hoşgün, Serdar Akpınar, et al.
Heart & Lung : the Journal of Critical Care|February 17, 2020
Morphological overview of cardiovascular comorbidities in chronic obstructive pulmonary disease: Frank's signNalan Ogan, Ersin Gunay, Berkay Ekici, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Clinical Respiratory Journal|December 29, 2019
Correlatıon of neutrophyle/lymphocyte ratio and pulmonary parameters with optic coherence tomography findings in stable chronic obstructive pulmonary diseasePinar Altiaylik Ozer, Nalan Ogan
Tuberkuloz Ve Toraks|November 12, 2019
Incidental pulmonary nodule frequency in TurkeyNalan Ogan, Ayşe Baha, Ebru Özan Sanhal, et al.
Turkish Thoracic Journal|October 8, 2020
The Effect of Serum Electrolyte Disturbances and Uric Acid Level on the Mortality of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseNalan Ogan, Ersin Günay, Ayşe Baha, et al.
Turkish Thoracic Journal|March 13, 2020
Does Nutritional Risk Screening 2002 Correlate with the Dyspnea Status of Patients with GOLD Stage C-D Chronic Obstructive Pulmonary Disease?Nalan Ogan, Fatma Yıldırım, Banu Süzen, et al.
Tuberkuloz Ve Toraks|January 5, 2026
The effect of intravenous low-dose thrombolytics on in-hospital mortality in patients with intermediate-high-risk pulmonary embolismAycan Yüksel, Ceren Ilgar Akelma, Nalan Ogan, et al.
Frontiers in Immunology|January 28, 2026
Serum paraoxonase-1 as a marker of oxidative stress and pulmonary dysfunction in sarcoidosis: association with disease activity and prognostic potentialMine Büşra Bozkürk, Ersin Günay, Nalan Ogan, et al.
European Journal of Clinical Pharmacology|February 24, 2024
Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?Onur Turan, Nalan Ogan, Fulsen Bozkus, et al.
Prostaglandins & Other Lipid Mediators|November 8, 2022
The association between total cholesterol and cognitive impairment in chronic obstructive pulmonary disease patientsHayriye Mihrimah Ozturk, Nalan Ogan, Mehmet Erdogan, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|August 15, 2019
Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia?Evrim Eylem Akpınar, Derya Hoşgün, Serdar Akpınar, et al.
Heart & Lung : the Journal of Critical Care|February 17, 2020
Morphological overview of cardiovascular comorbidities in chronic obstructive pulmonary disease: Frank's signNalan Ogan, Ersin Gunay, Berkay Ekici, et al.
Pageof 3